Skip to main content
4th of July Sale — Get 40% off Vantage subscriptions
Get Started
SubscribeLogin
Published • loading... • Updated

Why is the US targeting Germany's drug industry?

The probe could lead to tariffs as Washington says German pricing leaves U.S. patients paying more for innovative medicines, officials said.

Summary by Deutsche Welle
A new trade probe is reigniting a long-running clash over who should pay for medical innovation. Washington argues Germans benefit from lower prices while US patients shoulder a disproportionate share of the costs.

4 Articles

Hindustan TimesHindustan Times
Center

‘Ripping off the US’: Why is US targeting Germany's drug industry?

According to Donald Trump, every nation on the earth is "ripping off" the United States — that goes for pharmaceuticals, too, especially those from Germany.

·New Delhi, India
Read Full Article
fiercepharma.comfiercepharma.com
Center

Why can’t US just negotiate better drug prices with private pharma instead of punishing Germany’s government for successfully negotiating low prices?

Read Full Article
Deutsche WelleDeutsche Welle
Center

Why is the US targeting Germany's drug industry?

A new trade probe is reigniting a long-running clash over who should pay for medical innovation. Washington argues Germans benefit from lower prices while US patients shoulder a disproportionate share of the costs.

·Bonn, Germany
Read Full Article
Merca2.esMerca2.es

USA Investigates German Pharmaceutical for Its Low Prices and Threatens a Trade War

I have analysed in detail the decision of the US Trade Representation (UST) to open an investigation into the German regulation of drug prices. The inquiry, covered by Section 301 of the Trade Act 1974, questions that artificially low prices in the German pharmaceutical market constitute a covert subsidy that harms US laboratories. If Washington confirms its thesis, tariffs could be imposed on exports of the sector as of September, when the proc…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsche Welle broke the news in Bonn, Germany on Saturday, June 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Regulation icon

Regulation

Innovation icon

Innovation

International icon

International

Drug Prices icon

Drug Prices

Business icon

Business

Economy icon

Economy

Pharma icon

Pharma

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal